Responsible AI In Clinical Trials Starts With How It Is Designed

By Priyanka Sharma, Senior Vice President, Software Engineering, Suvoda

AI is moving from experimentation to real operational use in clinical trials, but adoption raises a fair question: how do you gain speed and consistency without losing the control this regulated industry demands? The answer lies in keeping human judgment at the center. Rather than letting AI make independent decisions, the most trustworthy systems are built on a core of structured rules, permissions, and expert-authored logic. AI works best when it's taught by people with deep trial experience to handle repetitive, time-consuming tasks like checking shipment issues or configuring complex randomization and supply logic. This is done while subject-matter experts continue to guide the judgment calls.

This same approach strengthens data protection by disabling AI's ability to access information beyond a user's clearance, such as data that would unblind a study. The result is meaningful efficiency gains, including dramatically faster study builds, without sacrificing the auditability and oversight regulators and sponsors require. For teams evaluating how to responsibly bring AI into trial operations, the challenge is finding technology that accelerates work while remaining fully transparent, governed, and grounded in clinical expertise.